They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

Similar documents
They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

Clinical guideline Published: 24 March 2010 nice.org.uk/guidance/cg95

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

Chest pain of recent onset: assessment and diagnosis

What is a myocardial infarction and how do we treat it? Paul Das Consultant Cardiologist North Wales Cardiac Centre Glan Clwyd Hospital

Unstable angina and NSTEMI

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

Choosing and delivering ering interventions entions for

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

Clinical guideline Published: 23 July 2011 nice.org.uk/guidance/cg126

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

Diagnostics guidance Published: 1 October 2014 nice.org.uk/guidance/dg15

This information explains the advice about the care and treatment of people with stable angina that is set out in NICE clinical guideline 126.

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

Ischaemic Heart Disease

Clinical guideline Published: 27 June 2012 nice.org.uk/guidance/cg143

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE. Proposed Health Technology Appraisal

Clinical guideline Published: 17 March 2008 nice.org.uk/guidance/cg64

Diagnostics consultation document

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Centre for Clinical Practice

The NICE chest pain guideline 1 year on. Jane S Skinner Consultant Community Cardiologist The Newcastle upon Tyne Hospitals NHS Foundation Trust

Interventional procedures guidance Published: 20 December 2017 nice.org.uk/guidance/ipg600

Preoperative tests (update)

Risk assessment for type 2 diabetes

Technology appraisal guidance Published: 14 December 2016 nice.org.uk/guidance/ta420

Medicine Dr. Omed Lecture 2 Stable and Unstable Angina

Chest Pain. Dr Robert Huggett Consultant Cardiologist

Acute coronary syndromes

Horizon Scanning Centre November 2012

Clinical guideline Published: 13 June 2012 nice.org.uk/guidance/cg141

TYPE II MI. KC ACDIS LOCAL CHAPTER March 8, 2016

Technology appraisal guidance Published: 23 July 2014 nice.org.uk/guidance/ta317

NICE Pathways bring together all NICE guidance, quality standards and other NICE information on a specific topic.

Chronic obstructive pulmonary disease in over 16s: diagnosis and management

Alcohol interventions in secondary and further education

HeartRescue Global Policy Brief STEMI: ST-segment elevation myocardial infarction. HeartRescue Global MEDTRONIC FOUNDATION

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE GUIDANCE EXECUTIVE (GE)

Technology appraisal guidance Published: 26 October 2011 nice.org.uk/guidance/ta236

Smoking cessation interventions and services

Putting NICE guidance into practice

Acute Myocardial Infarction. Willis E. Godin D.O., FACC

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

Chest pain of recent onset: Assessment and investigation of recent onset chest pain or discomfort of suspected cardiac origin.

Acute Coronary Syndrome. Sonny Achtchi, DO

NICE guideline Published: 6 July 2016 nice.org.uk/guidance/ng49

Interventional procedures guidance Published: 26 September 2014 nice.org.uk/guidance/ipg504

2 Benefits of depth of anaesthesia monitors

Sheffield guidelines for the use of antiplatelets in the prevention and treatment of cardiovascular disease (October 2017)

Medical Management of Acute Coronary Syndrome: The roles of a noncardiologist. Norbert Lingling D. Uy, MD Professor of Medicine UERMMMCI

Clinical guideline Published: 27 April 2011 nice.org.uk/guidance/cg122

Cardiology. Self Learning Package. Module 5: Pharmacology: Treatment of Acute Coronary. Prevention

Results of Ischemic Heart Disease

12 Lead EKG Chapter 4 Worksheet

Acute Coronary Syndrome. Cindy Baker, MD FACC Director Peripheral Vascular Interventions Division of Cardiovascular Medicine

URN: Family name: Given name(s): Address: Initial Signature Print Name Role

Cardiovascular Disorders Lecture 3 Coronar Artery Diseases

Medical technologies guidance Published: 2 October 2018 nice.org.uk/guidance/mtg39

Hyperparathyroidism (primary): diagnosis, assessment and initial management

Cairns Hospital: Suspected Acute Coronary Syndrome Pathways. DO NOT USE if a non cardiac cause for the chest pain can be diagnosed

Acute Myocardial Infarction

Guideline scope Hypertension in adults (update)

Clinical guideline Published: 23 February 2009 nice.org.uk/guidance/cg81

Otamixaban for non-st-segment elevation acute coronary syndrome

QOF indicator area: Chronic Obstructive Pulmonary disease (COPD)

ESM 1. Survey questionnaire sent to French GPs. Correct answers are in bold. Part 2: Clinical cases: (Good answer are in bold) Clinical Case 1:

IFT1 Interfacility Transfer of STEMI Patients. IFT2 Interfacility Transfer of Intubated Patients. IFT3 Interfacility Transfer of Stroke Patients

Myocardial perfusion scintigraphy for the diagnosis and management of angina and myocardial infarction

12 Lead Electrocardiogram (ECG) PFN: SOMACL17. Terminal Learning Objective. References

Case Report Left Main Stenosis. Percutaneous Coronary Intervention (PCI) or Coronary Artery Bypass Graft Surgery (CABG)?

DIFFERENTIATING THE PATIENT WITH UNDIFFERENTIATED CHEST PAIN

DIAGNOSTICS ASSESSMENT PROGRAMME

NICE guideline Published: 17 February 2016 nice.org.uk/guidance/ng38

Technology appraisal guidance Published: 20 December 2017 nice.org.uk/guidance/ta496

Transcription:

Assessment and immediate management of suspected acute coronary syndrome bring together everything NICE says on a topic in an interactive flowchart. are interactive and designed to be used online. They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see: http://pathways.nice.org.uk/pathways/chest-pain NICE Pathway last updated: 27 March 2018 This document contains a single flowchart and uses numbering to link the boxes to the associated recommendations. Page 1 of 10

Page 2 of 10

1 Person with a suspected acute coronary syndrome No additional information 2 Initial assessment Check immediately whether people currently have chest pain. If they are pain free, check when their last episode of pain was, particularly if they have had pain in the last 12 hours. Determine whether the chest pain may be cardiac and therefore whether this guidance is relevant, by considering: the history of the chest pain the presence of cardiovascular risk factors history of ischaemic heart disease and any previous treatment previous investigations for chest pain. Initially assess people for any of the following symptoms, which may indicate an acute coronary syndrome: pain in the chest and/or other areas (for example, the arms, back or jaw) lasting longer than 15 minutes chest pain associated with nausea and vomiting, marked sweating, breathlessness, or particularly a combination of these chest pain associated with haemodynamic instability new onset chest pain, or abrupt deterioration in previously stable angina, with recurrent chest pain occurring frequently and with little or no exertion, and with episodes often lasting longer than 15 minutes. Do not use people's response to GTN to make a diagnosis. Do not assess symptoms of an acute coronary syndrome differently in men and women. Not all people with an acute coronary syndrome present with central chest pain as the predominant feature. Do not assess symptoms of an acute coronary syndrome differently in ethnic groups. There are no major differences in symptoms of an acute coronary syndrome among different ethnic groups. Page 3 of 10

3 Immediate management of suspected acute coronary syndrome When an acute coronary syndrome is suspected, start management immediately in the order appropriate to the circumstances and take a resting 12-lead ECG. Take the ECG as soon as possible, but do not delay transfer to hospital. Take a resting 12-lead ECG as soon as possible. When people are referred, send the results to hospital before they arrive if possible. Recording and sending the ECG should not delay transfer to hospital. Offer pain relief as soon as possible. This may be achieved with GTN (sublingual or buccal), but offer intravenous opioids such as morphine, particularly if an acute myocardial infarction is suspected. Offer people a single loading dose of 300 mg aspirin as soon as possible unless there is clear evidence that they are allergic to it. If aspirin is given before arrival at hospital, send a written record that it has been given with the person. Only offer other antiplatelet agents in hospital. Follow appropriate guidance on the early management of unstable angina and NSTEMI or local protocols for STEMI. Do not routinely administer oxygen, but monitor oxygen saturation using pulse oximetry as soon as possible, ideally before hospital admission. Only offer supplemental oxygen to: people with oxygen saturation (SpO 2 ) of less than 94% who are not at risk of hypercapnic respiratory failure, aiming for SpO 2 of 94 98% people with chronic obstructive pulmonary disease who are at risk of hypercapnic respiratory failure, to achieve a target SpO 2 of 88 92% until blood gas analysis is available. Monitor people with acute chest pain, using clinical judgement to decide how often this should be done, until a firm diagnosis is made. This should include: exacerbations of pain and/or other symptoms pulse and blood pressure heart rhythm oxygen saturation by pulse oximetry repeated resting 12-lead ECGs and Page 4 of 10

checking pain relief is effective. Manage other therapeutic interventions using appropriate guidance (early management of unstable angina and NSTEMI or local protocols for STEMI). Nasal Alar SpO2 sensor NICE has published a medtech innovation briefing on Nasal Alar SpO2 sensor for monitoring oxygen saturation by pulse oximetry. 4 Acute coronary syndrome not suspected If an acute coronary syndrome is not suspected, consider other causes of the chest pain, some of which may be life-threatening. If an acute coronary syndrome has been excluded at any point in the care pathway, but people have risk factors for cardiovascular disease, follow the appropriate guidance, for example in NICE's recommendations on cardiovascular disease prevention or hypertension. 5 When to refer to hospital Refer people to hospital as an emergency if an acute coronary syndrome is suspected (see initial assessment [See page 3]) and: they currently have chest pain or they are currently pain free, but had chest pain in the last 12 hours, and a resting 12-lead ECG is abnormal or not available. Refer people to hospital as an emergency if they have a recent (confirmed or suspected) acute coronary syndrome and develop further chest pain. If an acute coronary syndrome is suspected and there are no reasons for emergency referral, refer people for urgent same-day assessment if: they had chest pain in the last 12 hours, but are now pain free with a normal resting 12-lead ECG or the last episode of pain was 12 72 hours ago. Refer people for assessment in hospital if an acute coronary syndrome is suspected and: Page 5 of 10

the pain has resolved and there are signs of complications such as pulmonary oedema. Use clinical judgement to decide whether referral should be as an emergency or urgent sameday assessment. If a recent acute coronary syndrome is suspected in people whose last episode of chest pain was more than 72 hours ago and who have no complications such as pulmonary oedema: carry out a detailed clinical assessment (see the recommendations on physical examination and detailed clinical history for the initial assessment in hospital) confirm the diagnosis by resting 12-lead ECG and blood troponin level take into account the length of time since the suspected acute coronary syndrome when interpreting the troponin level. Use clinical judgement to decide whether referral is necessary and how urgent this should be. 6 Tests in hospital See / Tests in hospital for people with a suspected acute coronary syndrome Page 6 of 10

Glossary ACE angiotensin-converting enzyme BIS Bispectral Index CABG coronary artery bypass graft ECG electrocardiogram EEG electroencephalography GRACE Global Registry of Acute Coronary Events GTN glyceryl trinitrate MPS with SPECT myocardial perfusion scintigraphy with single photon emission CT NSTEMI non-st-segment elevation myocardial infarction PCI percutaneous coronary intervention Page 7 of 10

SPECT single photon emission CT STEMI ST-segment elevation myocardial infarction ST-T ST-segment-T-wave Sources of recent onset: assessment and diagnosis (2010 updated 2016) NICE guideline CG95 Your responsibility Guidelines The recommendations in this guideline represent the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, professionals and practitioners are expected to take this guideline fully into account, alongside the individual needs, preferences and values of their patients or the people using their service. It is not mandatory to apply the recommendations, and the guideline does not override the responsibility to make decisions appropriate to the circumstances of the individual, in consultation with them and their families and carers or guardian. Local commissioners and providers of healthcare have a responsibility to enable the guideline to be applied when individual professionals and people using services wish to use it. They should do so in the context of local and national priorities for funding and developing services, and in light of their duties to have due regard to the need to eliminate unlawful discrimination, to advance equality of opportunity and to reduce health inequalities. Nothing in this guideline should be interpreted in a way that would be inconsistent with complying with those duties. Page 8 of 10

Commissioners and providers have a responsibility to promote an environmentally sustainable health and care system and should assess and reduce the environmental impact of implementing NICE recommendations wherever possible. Technology appraisals The recommendations in this interactive flowchart represent the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, health professionals are expected to take these recommendations fully into account, alongside the individual needs, preferences and values of their patients. The application of the recommendations in this interactive flowchart is at the discretion of health professionals and their individual patients and do not override the responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient, in consultation with the patient and/or their carer or guardian. Commissioners and/or providers have a responsibility to provide the funding required to enable the recommendations to be applied when individual health professionals and their patients wish to use it, in accordance with the NHS Constitution. They should do so in light of their duties to have due regard to the need to eliminate unlawful discrimination, to advance equality of opportunity and to reduce health inequalities. Commissioners and providers have a responsibility to promote an environmentally sustainable health and care system and should assess and reduce the environmental impact of implementing NICE recommendations wherever possible. Medical technologies guidance, diagnostics guidance and interventional procedures guidance The recommendations in this interactive flowchart represent the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, healthcare professionals are expected to take these recommendations fully into account. However, the interactive flowchart does not override the individual responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient, in consultation with the patient and/or guardian or carer. Page 9 of 10

Commissioners and/or providers have a responsibility to implement the recommendations, in their local context, in light of their duties to have due regard to the need to eliminate unlawful discrimination, advance equality of opportunity, and foster good relations. Nothing in this interactive flowchart should be interpreted in a way that would be inconsistent with compliance with those duties. Commissioners and providers have a responsibility to promote an environmentally sustainable health and care system and should assess and reduce the environmental impact of implementing NICE recommendations wherever possible. Page 10 of 10